Bioptigen Spectral Domain Ophthalmic Imaging System
Ophthalmoscope, Ac-Powered. 510(k) K063343, from Bioptigen, Inc. (Washington, DC). Product code HLI, class 2.
As of Nov 19, 2026, K063343 is an FDA 510(k) held by Bioptigen, Inc., substantially equivalent on Dec 13, 2006 after 37 days, with no recalls tied to it in FDA's recall database.
- Review time: 37 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The Bioptigen Spectral Domain Ophthalmic Imaging System is intended to acquire, process, display, and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography. It is primarily intended for the imaging of retinal tissue, but the cornea, sclera, and conjunctiva can also be imaged by changing the focal position.
- Stratusoct With Rnfl & Macula Normative DatabaseK033123 · Carl Zeiss Meditec, Inc. · Apr 20, 2004
- Humphrey OCT3K012727 · Carl Zeiss Ophthalmic Systems, Inc. · Jan 31, 2002
- Envisu Spectral Domain Ophthalmic Imaging System (Sdois)K120057 · Bioptigen, Inc. · May 11, 2012
- Ca, Model: CamK071250 · Optovue, Inc. · Sep 28, 2007
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional, third-party review
- Received
- Nov 6, 2006
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files